Isotechnika Pharma Inc IPHAF

Halt

[northernwinds]

How would a halt assist share price, the initial release allocated for a continuation of the fast track, by that it defined that the issues were not pertinent to it moving forward.  And to date we really don't know what the issues are. The only real travesty is the fact that the FDA can delay or dismiss a meeting on such short notice without defining the issues. It plays havoc with a stocks price and leads to the kind of fear mongering speculation that has been present. Unfortunatly the FDA does not seem to consider the economic impact of it's actions, and LUX really isn't concerned either as they do  not appear to be a publically traded company. ISA is really the only group affected by the delay. This is one of the flaws of the system, obviously by the news releases, ISA thinks they have a winner. You can speculate all you want on why the meeting was cancelled, the only real tangible information out of the news release was that the Fast Track is still an option, assuming Lux can provide the requested data!